Free Trial

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group logo
$303.08 -0.14 (-0.05%)
Closing price 06/9/2025 03:59 PM Eastern
Extended Trading
$303.40 +0.32 (+0.11%)
As of 06/9/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UnitedHealth Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
6
Buy
17

Based on 24 Wall Street analysts who have issued ratings for UnitedHealth Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 24 analysts, 1 has given a sell rating, 6 have given a hold rating, and 17 have given a buy rating for UNH.

Consensus Price Target

$428.43
41.36% Upside
According to the 24 analysts' twelve-month price targets for UnitedHealth Group, the average price target is $428.43. The highest price target for UNH is $700.00, while the lowest price target for UNH is $270.00. The average price target represents a forecasted upside of 41.36% from the current price of $303.08.
Get the Latest News and Ratings for UNH and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for UnitedHealth Group and its competitors.

Sign Up

UNH Analyst Ratings Over Time

TypeCurrent Forecast
6/10/24 to 6/10/25
1 Month Ago
5/11/24 to 5/11/25
3 Months Ago
3/12/24 to 3/12/25
1 Year Ago
6/11/23 to 6/10/24
Strong Buy
0 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
17 Buy rating(s)
18 Buy rating(s)
19 Buy rating(s)
17 Buy rating(s)
Hold
6 Hold rating(s)
4 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$428.43$596.86$629.32$578.75
Forecasted Upside41.36% Upside56.77% Upside30.79% Upside16.92% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Buy
Moderate Buy

UNH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

UNH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

UnitedHealth Group Stock vs. The Competition

TypeUnitedHealth GroupMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.81
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside41.36% Upside5,942.23% Upside13.44% Upside
News Sentiment Rating
Positive News

See Recent UNH News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/6/2025Wells Fargo & Company
3 of 5 stars
 Reiterated RatingOverweight ➝ Overweight
6/3/2025Piper Sandler
2 of 5 stars
Jessica Tassan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$552.00 ➝ $353.00+16.80%
6/2/2025Barclays
3 of 5 stars
Andrew Mok
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$350.00+13.22%
6/2/2025KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Matthew Gillmor
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$450.00 ➝ $400.00+32.86%
5/21/2025Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Herholdt
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
5/21/2025HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sidharth Sahoo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Reduce$490.00 ➝ $270.00-16.09%
5/20/2025Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Justin Lake
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$501.00 ➝ $390.00+21.90%
5/19/2025TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ryan Langston
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$520.00 ➝ $308.00-1.39%
5/19/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Macdonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$580.00 ➝ $360.00+19.78%
5/19/2025TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Langston
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold$308.00+5.75%
5/16/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ann Hynes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$515.00 ➝ $350.00+21.81%
5/16/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ben Hendrix
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$525.00 ➝ $355.00+23.45%
5/15/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lisa Gill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$525.00 ➝ $405.00+31.34%
5/14/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
George Hill
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$521.00 ➝ $362.00+16.14%
5/14/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Wiederhorn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$600.00 ➝ $400.00+27.23%
5/14/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ricky Goldwasser
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$563.00 ➝ $374.00+17.10%
5/14/2025Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Ransom
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Market Perform
5/14/2025Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kevin Fischbeck
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral$560.00 ➝ $350.00+9.04%
5/14/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$510.00 ➝ $356.00+14.38%
4/30/2025Erste Group Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
H. Engel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/21/2025Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Toung
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
1/17/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sarah James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$700.00 ➝ $700.00+36.71%
12/5/2024Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$605.00 ➝ $675.00+10.54%
10/16/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$680.00 ➝ $650.00+13.16%
7/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$481.00 ➝ $647.00+17.88%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/18/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$595.00 ➝ $603.00+24.55%
6/14/2023SVB Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$625.00 ➝ $560.00+13.98%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 02:25 AM ET.


Should I Buy UnitedHealth Group Stock? UNH Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Sunday, June 8, 2025. Please send any questions or comments about these UnitedHealth Group pros and cons to contact@marketbeat.com.

UnitedHealth Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in UnitedHealth Group:

  • The current stock price is around $428, which reflects a significant potential for growth based on analyst ratings.
  • UnitedHealth Group has a strong dividend yield of approximately 2.92%, providing investors with a steady income stream.
  • The company has a low payout ratio of 37.02%, indicating that it retains a substantial portion of its earnings for reinvestment and growth.
  • Recent analyst ratings show a consensus of "Moderate Buy," with a majority of analysts recommending the stock as a good investment opportunity.
  • Insider buying activity has increased, with insiders purchasing over 109,000 shares recently, suggesting confidence in the company's future performance.

UnitedHealth Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in UnitedHealth Group for these reasons:

  • Several analysts have downgraded their ratings recently, indicating a shift in market sentiment towards caution.
  • Price targets have been significantly reduced by multiple analysts, suggesting that expectations for future growth may be tempered.
  • There is a notable level of uncertainty in the healthcare sector, which could impact UnitedHealth Group's performance.
  • Despite a strong dividend, the overall market volatility may pose risks to stock price stability.
  • With only 0.33% of the stock owned by insiders, there may be limited alignment between management and shareholder interests.

UNH Forecast - Frequently Asked Questions

According to the research reports of 24 Wall Street equities research analysts, the average twelve-month stock price forecast for UnitedHealth Group is $428.43, with a high forecast of $700.00 and a low forecast of $270.00.

24 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UnitedHealth Group in the last twelve months. There is currently 1 sell rating, 6 hold ratings and 17 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" UNH shares.

According to analysts, UnitedHealth Group's stock has a predicted upside of 41.36% based on their 12-month stock forecasts.

Over the previous 90 days, UnitedHealth Group's stock had 7 downgrades and 1 upgrade by analysts.

Analysts like UnitedHealth Group less than other "medical" companies. The consensus rating score for UnitedHealth Group is 2.67 while the average consensus rating score for "medical" companies is 2.81. Learn more on how UNH compares to other companies.


This page (NYSE:UNH) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners